Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.3297
-0.0103 (-3.03%)
May 14, 2025, 1:46 PM - Market open
APVO's stock price has decreased by -98.9% in the past year and price targets may not have had time to catch up.
Aptevo Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$296.00
Upside
+89,678.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $555 → $296 | Strong Buy | Maintains | $555 → $296 | +89,678.59% | Sep 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $112,332 → $32,560 | Buy | Maintains | $112,332 → $32,560 | +9,875,544.53% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $104,192 → $81,400 | Strong Buy | Maintains | $104,192 → $81,400 | +24,689,011.31% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $52,096 → $112,332 | Buy | Maintains | $52,096 → $112,332 | +34,070,873.61% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $273,504 | Strong Buy | Initiates | $273,504 | +82,955,314.01% | Apr 11, 2018 |
| Piper Sandler | Piper Sandler | Buy Initiates $159,544 | Buy | Initiates | $159,544 | +48,390,558.17% | Sep 9, 2016 |